Table 11.6e

Immunosuppression Use for Maintenance

		Year of Transplant
		2000	2001	2002	2003	2004	2005	2006	2007	2008	2009
Functioning Graft at Discharge		1,982	2,008	1,977	1,899	1,867	1,956	2,038	2,070	2,037	2,075
With Immunosuppression Info		1,976	1,983	1,966	1,885	1,854	1,934	1,998	2,059	2,028	2,060
Corticosteroids	Any in Category	94.4%	97.2%	96.9%	92.6%	92.0%	93.3%	92.2%	88.8%	87.4%	88.7%
Corticosteroids	Steroids	94.4%	97.2%	96.9%	92.6%	92.0%	93.3%	92.2%	88.8%	87.4%	88.7%
Cyclosporine	Any in Category	80.4%	70.3%	60.1%	58.5%	50.9%	40.1%	38.1%	33.0%	25.6%	18.7%
	Cyclosporin	0.1%	0.1%	0.1%	0.1%	0.2%	0.6%	1.4%	1.1%	1.5%	1.2%
	Sandimmmune	8.1%	4.3%	2.8%	3.4%	2.9%	2.1%	1.5%	1.2%	0.6%	1.0%
	Neoral	70.6%	57.7%	44.5%	40.6%	33.3%	25.5%	26.8%	23.5%	17.7%	11.7%
	Gengraf	1.6%	8.1%	12.6%	14.3%	14.2%	11.2%	8.3%	7.0%	5.5%	4.2%
	Eon	0.0%	0.2%	0.2%	0.1%	0.4%	0.7%	0.2%	0.2%	0.3%	0.6%
Tacrolimus	Any in Category	16.0%	30.2%	39.6%	41.7%	47.0%	57.8%	59.6%	65.4%	73.1%	79.1%
	Tacrolimus	16.0%	30.2%	39.6%	41.7%	47.0%	57.8%	59.6%	65.0%	72.4%	78.6%
	Everolimus	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.4%	0.6%	0.5%
Antimetabolites	Any in Category	88.2%	91.0%	84.4%	89.2%	94.9%	94.3%	91.4%	91.9%	92.8%	92.0%
	Mycophenolate Mofetil	68.3%	75.8%	71.7%	79.6%	85.3%	84.7%	83.4%	85.6%	87.3%	85.2%
	Mycophenolate Sodium	0.0%	0.0%	0.4%	0.2%	0.1%	1.4%	3.4%	3.4%	2.7%	3.7%
	Azathioprine	19.5%	14.9%	12.2%	9.3%	9.5%	8.1%	4.7%	2.9%	2.8%	3.1%
	Leflunomide	0.0%	0.0%	0.1%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
	Cytoxan	0.4%	0.3%	0.2%	0.1%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
mTOR Inhibitors	Any in Category	2.9%	4.3%	10.0%	8.4%	5.3%	4.1%	6.2%	4.5%	3.4%	1.9%
	Sirolimus	2.6%	4.3%	10.0%	8.4%	5.2%	3.8%	3.7%	1.2%	1.0%	1.4%
	Everolimus	0.4%	0.0%	0.1%	0.0%	0.2%	0.4%	2.6%	3.3%	2.4%	0.5%